Considering that the risk of developing TB due to the reactivation of LTBI was highest during the first 6–12 months of anti-TNF therapy [3, 40–42], there was a possibility that some of these patients could develop TB due to recent new infection with M. tuberculosis. The gene discussed is TNF; the disease is infection.